FDA Extends Comment Period on Guidance Regarding Alternative Name of Potassium Chloride

FDA Extends Comment Period on Guidance Regarding Alternative Name of Potassium Chloride

July 9, 2019

The U.S. Food and Drug Administration is extending by 60 days, until September 17, 2019, the comment period on the draft guidance, “The Use of an Alternate Name for Potassium Chloride in Food Labeling.”  The original comment period was scheduled to end on July 19.

The agency is taking this action in response to requests for additional time to submit comments. FDA believes that the extension will allow adequate time for interested persons to provide input.

The FDA is announcing the extension in the Federal Register.

How to Comment

To submit electronic comments, go to https://www.regulations.gov to Docket Folder FDA-2019-N-0892.

Written comments must be sent to: Docket Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. All submissions received must include the Docket No. FDA-2019-0892.

Further instructions can be found in the Notice of Availability; extension of comment period.